DK1732604T3 - Fremgangsmåder til behandling af hiv-infektion - Google Patents

Fremgangsmåder til behandling af hiv-infektion

Info

Publication number: DK1732604T3
Authority: DK; Denmark
Prior art keywords: methods; hiv infection; treating hiv; treating; infection
Prior art date: 2004-03-24

Application number

DK05723932.9T

Other languages

English (en)

Inventor

Pin-Fang Lin

Beata Nowicka-Sans

Gregory Yamanaka

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-24

Filing date

2005-03-01

Publication date

2010-11-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34961940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1732604(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-03-01 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

2010-11-15 Application granted granted Critical

2010-11-15 Publication of DK1732604T3 publication Critical patent/DK1732604T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK05723932.9T 2004-03-24 2005-03-01 Fremgangsmåder til behandling af hiv-infektion DK1732604T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US55576704P	2004-03-24	2004-03-24
PCT/US2005/006277 WO2005102392A2 (en)	2004-03-24	2005-03-01	Combinations for treating hiv infection

Publications (1)

Publication Number	Publication Date
DK1732604T3 true DK1732604T3 (da)	2010-11-15

Family

ID=34961940

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05723932.9T DK1732604T3 (da)	2004-03-24	2005-03-01	Fremgangsmåder til behandling af hiv-infektion

Country Status (30)

Country	Link
US (1)	US7776863B2 (da)
EP (1)	EP1732604B1 (da)
JP (1)	JP4847441B2 (da)
KR (1)	KR101158140B1 (da)
CN (1)	CN1956720B (da)
AR (1)	AR048333A1 (da)
AT (1)	ATE474602T1 (da)
AU (1)	AU2005235116B2 (da)
BR (1)	BRPI0509140A (da)
CA (1)	CA2561146C (da)
CY (1)	CY1111613T1 (da)
DE (1)	DE602005022420D1 (da)
DK (1)	DK1732604T3 (da)
ES (1)	ES2347801T3 (da)
GE (1)	GEP20104925B (da)
HR (1)	HRP20100434T1 (da)
IL (1)	IL178141A (da)
IN (1)	IN2012DN06436A (da)
MY (1)	MY144318A (da)
NO (1)	NO337116B1 (da)
NZ (1)	NZ549778A (da)
PE (1)	PE20060148A1 (da)
PL (1)	PL1732604T3 (da)
PT (1)	PT1732604E (da)
RU (1)	RU2367439C2 (da)
SI (1)	SI1732604T1 (da)
TW (1)	TWI347184B (da)
UA (1)	UA88463C2 (da)
WO (1)	WO2005102392A2 (da)
ZA (1)	ZA200607959B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040110785A1 (en) *	2001-02-02	2004-06-10	Tao Wang	Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US7745625B2 (en)	2004-03-15	2010-06-29	Bristol-Myers Squibb Company	Prodrugs of piperazine and substituted piperidine antiviral agents
US20060100432A1 (en) *	2004-11-09	2006-05-11	Matiskella John D	Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US20060100209A1 (en) *	2004-11-09	2006-05-11	Chong-Hui Gu	Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
WO2007049771A1 (ja)	2005-10-28	2007-05-03	Ono Pharmaceutical Co., Ltd.	塩基性基を含有する化合物およびその用途
WO2007058322A1 (ja)	2005-11-18	2007-05-24	Ono Pharmaceutical Co., Ltd.	塩基性基を含有する化合物およびその用途
US7851476B2 (en) *	2005-12-14	2010-12-14	Bristol-Myers Squibb Company	Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2 (en) *	2006-04-25	2010-10-05	Bristol-Myers Squibb Company	Diketo-piperazine and piperidine derivatives as antiviral agents
US7501419B2 (en) *	2006-04-25	2009-03-10	Bristol-Myers Squibb Company	4-Squarylpiperazine derivatives as antiviral agents
US7504399B2 (en)	2006-06-08	2009-03-17	Bristol-Meyers Squibb Company	Piperazine enamines as antiviral agents
US7572810B2 (en) *	2006-06-08	2009-08-11	Bristol-Myers Squibb Company	Alkene piperidine derivatives as antiviral agents
JP5433691B2 (ja) *	2008-06-25	2014-03-05	ブリストル−マイヤーズスクイブカンパニー	Ｈｉｖ結合阻害剤としてのジケトピペリジン誘導体
WO2009158394A1 (en) *	2008-06-25	2009-12-30	Bristol-Myers Squibb Company	Diketo azolopiperidines and azolopiperazines as anti-hiv agents
US20110295365A1 (en) *	2010-05-28	2011-12-01	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Anti-viral compositions and methods for administration
US8450361B2 (en)	2010-08-06	2013-05-28	Bristol-Myers Squibb Company	Substituted indole and azaindole oxoacetyl piperazinamide derivatives
EP2646439B1 (en)	2010-12-02	2016-05-25	Bristol-Myers Squibb Company	Alkyl amides as hiv attachment inhibitors
RS54055B1 (sr)	2011-01-31	2015-10-30	Bristol-Myers Squibb Company	POSTUPCI ZA PRIPREMU JEDINJENJA PROLEKA INHIBITORA VEZIVANJA HIV-a I INTERMEDIJERA
US8685982B2 (en)	2011-04-12	2014-04-01	Bristol-Myers Squibb Company	Thioamide, amidoxime and amidrazone derivatives as HIV attachment inhibitors
WO2013033061A1 (en)	2011-08-29	2013-03-07	Bristol-Myers Squibb Company	Fused bicyclic diamine derivatives as hiv attachment inhibitors
US8664213B2 (en)	2011-08-29	2014-03-04	Bristol-Myers Squibb Company	Spiro bicyclic diamine derivatives as HIV attachment inhibitors
WO2013138436A1 (en)	2012-03-14	2013-09-19	Bristol-Myers Squibb Company	Cyclolic hydrazine derivatives as hiv attachment inhibitors
WO2014025852A1 (en)	2012-08-09	2014-02-13	Bristol-Myers Squibb Company	Tricyclic alkene derivatives as hiv attachment inhibitors
WO2014025854A1 (en)	2012-08-09	2014-02-13	Bristol-Myers Squibb Company	Piperidine amide derivatives as hiv attachment inhibitors
EP2978763B1 (en) *	2013-03-27	2018-03-07	VIIV Healthcare UK (No.5) Limited	2-keto amide derivatives as hiv attachment inhibitors
WO2016210130A1 (en) *	2015-06-23	2016-12-29	Cytodyn Inc.	Inhibition of ccl5 ligand binding to ccr5 receptor and alteration of ccr5/ccl5 axis signaling in inflammation, cancer, autoimmune, and other conditions
US20250237642A1 (en) *	2022-03-08	2025-07-24	Emory University	Predictive model for variants associated with drug resistance and theranostic applications thereof
US12425371B2 (en) *	2022-09-16	2025-09-23	Cisco Technology, Inc.	System and method for providing SCHC-based edge firewalling

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69934486T2 (de) *	1998-03-02	2007-10-04	The University Of North Carolina At Chapel Hill Office Of Technology Development	Acylierte betulin- und dihydrobetulinderivate, ihre herstellung und verwendung
US6476034B2 (en) *	2000-02-22	2002-11-05	Bristol-Myers Squibb Company	Antiviral azaindole derivatives
US20040110785A1 (en) *	2001-02-02	2004-06-10	Tao Wang	Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US20030207910A1 (en) *	2001-02-02	2003-11-06	Tao Wang	Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
RU2192870C1 (ru) *	2001-07-02	2002-11-20	Закрытое акционерное общество "Агрофарм ПитерСиб"	Антивирусная композиция, способ получения ее активной компоненты и способ лечения вич-инфицированных больных этой композицией
CA2469592C (en) *	2001-12-12	2005-08-23	Bristol-Myers Squibb Company	Hiv integrase inhibitors
CN1596255A (zh) *	2001-12-21	2005-03-16	阿诺麦德股份有限公司	具有强效的与趋化因子受体结合的杂环化合物

2005
- 2005-02-24 US US11/064,683 patent/US7776863B2/en active Active
- 2005-03-01 CA CA2561146A patent/CA2561146C/en not_active Expired - Lifetime
- 2005-03-01 IN IN6436DEN2012 patent/IN2012DN06436A/en unknown
- 2005-03-01 BR BRPI0509140-3A patent/BRPI0509140A/pt not_active Application Discontinuation
- 2005-03-01 JP JP2007504971A patent/JP4847441B2/ja not_active Expired - Lifetime
- 2005-03-01 AT AT05723932T patent/ATE474602T1/de active
- 2005-03-01 DK DK05723932.9T patent/DK1732604T3/da active
- 2005-03-01 HR HR20100434T patent/HRP20100434T1/hr unknown
- 2005-03-01 WO PCT/US2005/006277 patent/WO2005102392A2/en not_active Ceased
- 2005-03-01 KR KR1020067019595A patent/KR101158140B1/ko not_active Expired - Lifetime
- 2005-03-01 ES ES05723932T patent/ES2347801T3/es not_active Expired - Lifetime
- 2005-03-01 GE GEAP20059667A patent/GEP20104925B/en unknown
- 2005-03-01 RU RU2006137555/14A patent/RU2367439C2/ru active
- 2005-03-01 DE DE602005022420T patent/DE602005022420D1/de not_active Expired - Lifetime
- 2005-03-01 CN CN2005800160669A patent/CN1956720B/zh not_active Expired - Lifetime
- 2005-03-01 AU AU2005235116A patent/AU2005235116B2/en not_active Expired
- 2005-03-01 SI SI200531100T patent/SI1732604T1/sl unknown
- 2005-03-01 PT PT05723932T patent/PT1732604E/pt unknown
- 2005-03-01 EP EP05723932A patent/EP1732604B1/en not_active Expired - Lifetime
- 2005-03-01 NZ NZ549778A patent/NZ549778A/en not_active IP Right Cessation
- 2005-03-01 PL PL05723932T patent/PL1732604T3/pl unknown
- 2005-03-01 UA UAA200611163A patent/UA88463C2/ru unknown
- 2005-03-17 MY MYPI20051136A patent/MY144318A/en unknown
- 2005-03-18 TW TW094108462A patent/TWI347184B/zh not_active IP Right Cessation
- 2005-03-23 AR ARP050101159A patent/AR048333A1/es not_active Application Discontinuation
- 2005-03-28 PE PE2005000344A patent/PE20060148A1/es not_active Application Discontinuation
2006
- 2006-09-17 IL IL178141A patent/IL178141A/en active IP Right Review Request
- 2006-09-22 ZA ZA200607959A patent/ZA200607959B/en unknown
- 2006-10-06 NO NO20064547A patent/NO337116B1/no unknown
2010
- 2010-10-20 CY CY20101100937T patent/CY1111613T1/el unknown

Also Published As

Publication number	Publication date
IL178141A0 (en)	2006-12-31
IL178141A (en)	2010-11-30
WO2005102392A3 (en)	2006-07-20
TW200538117A (en)	2005-12-01
CN1956720B (zh)	2010-12-15
CA2561146A1 (en)	2005-11-03
ES2347801T3 (es)	2010-11-04
AR048333A1 (es)	2006-04-19
CN1956720A (zh)	2007-05-02
IN2012DN06436A (da)	2015-10-09
KR101158140B1 (ko)	2012-06-19
JP2007530540A (ja)	2007-11-01
NZ549778A (en)	2010-09-30
BRPI0509140A (pt)	2007-09-04
MY144318A (en)	2011-08-29
EP1732604B1 (en)	2010-07-21
US20050215545A1 (en)	2005-09-29
DE602005022420D1 (de)	2010-09-02
KR20070011322A (ko)	2007-01-24
SI1732604T1 (sl)	2010-10-29
JP4847441B2 (ja)	2011-12-28
RU2006137555A (ru)	2008-04-27
AU2005235116A1 (en)	2005-11-03
AU2005235116B2 (en)	2011-03-31
PE20060148A1 (es)	2006-03-04
EP1732604A2 (en)	2006-12-20
US7776863B2 (en)	2010-08-17
GEP20104925B (en)	2010-03-25
TWI347184B (en)	2011-08-21
HRP20100434T1 (hr)	2010-09-30
PT1732604E (pt)	2010-09-24
WO2005102392A2 (en)	2005-11-03
HK1096540A1 (en)	2007-06-01
UA88463C2 (ru)	2009-10-26
NO20064547L (no)	2006-10-06
NO337116B1 (no)	2016-01-25
CA2561146C (en)	2013-12-24
ZA200607959B (en)	2008-06-25
RU2367439C2 (ru)	2009-09-20
PL1732604T3 (pl)	2010-12-31
ATE474602T1 (de)	2010-08-15
CY1111613T1 (el)	2015-10-07

Publication	Publication Date	Title
DK1732604T3 (da)	2010-11-15	Fremgangsmåder til behandling af hiv-infektion
DK1720571T3 (da)	2012-09-03	Fremgangsmåde til behandling af hæmolytisk sygdom
DK1828164T3 (da)	2008-12-08	Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da)	2013-09-30	Fremgangsmåde til fremstilling af dihydropteridion
DK1802334T3 (da)	2012-10-15	Fremgangsmåde til behandling af intraokulære, neovaskulære sygdomme
DK1575416T3 (da)	2014-01-13	Fremgangsmåder til diagnosticering af præeklampsi
DK1997512T3 (da)	2014-01-27	Fremgangsmåder til behandling af TWEAK-relaterede tilstande
DK1745052T3 (da)	2009-01-05	HIV-intergrase-inhibitorer: cykliske pyrimidinonforbindelser
DK1737461T3 (da)	2013-03-18	Carbolin-derivater til inhibering af angiogenese
DK1718608T3 (da)	2013-10-14	Virale polymeraseinhibitorer
NO20070251A (no)	2007-03-12	Brønnbehandling
CY2200156T2 (el)	2010-07-28	Επεξεργασια λυματων
NO20070297A (no)	2007-03-12	Brønnbehandling
EP1771442A4 (en)	2009-12-30	INHIBITORS OF VIRAL POLYMERASE
DE602005022897D1 (de)	2010-09-23	Piperidinylamino-thienoä2,3-dü-pyrimidinverbindungen
DK3403657T3 (da)	2022-02-28	Anvendelse af oligouronater til behandling af slimhyperviskositet
DK1776136T3 (da)	2012-12-03	Behandling af tilstande, der involverer demyelinisering
EP1732707A4 (en)	2009-10-21	ACTIVATION METHOD
DK1744781T3 (da)	2012-10-15	Behandling af infektionssygdomme
EP1765735A4 (en)	2009-12-30	SLUDGE TREATMENT PROCESS
DK1831223T3 (da)	2013-06-10	Fremgangsmåde til fremstilling af L-biopterin
DK4070800T3 (da)	2025-01-02	Cladribinkur til behandling af multipel sklerose
DK1812002T3 (da)	2012-02-06	Behandling af mastitis
DK1814555T3 (da)	2009-12-07	S-mirtazapin til behandling af hedeture
DE112005001784A5 (de)	2007-05-31	Geruchsverschluss